Genes on Y chromosome protect against pulmonary hypertension, study suggests

December 5, 2017 by Ryan Hatoum, University of California, Los Angeles

A new UCLA study suggests that the Y chromosome provides protection against the development of pulmonary hypertension and may be the reason the disease is less prevalent among men than women. The researcher found that mice with Y chromosomes were significantly less likely to develop severe pulmonary hypertension than mice without Y chromosomes.

The findings suggest for the first time that sex chromosomes—not only sex hormones—may explain why women, who typically do not have a Y chromosome, are more susceptible to the than men.

Pulmonary hypertension, a chronic disease characterized by affecting the arteries and heart, appears most often in young women. It has no definitive cure and can be fatal. Many patients eventually require a lung transplant, a costly procedure that carries its own risks and requires a donor. Being male is the single biggest factor in avoiding development of .

Previous studies have investigated sex hormones as a factor in the development of pulmonary hypertension. This study is the first to examine the involvement of sex chromosomes in the disease's development in the absence of sex hormones. In humans, females typically have two copies of the X chromosome, while males typically have one X and one Y chromosome.

In the lab, the researchers engineered mice with different chromosomal makeups and measured their development of pulmonary hypertension in an environment with 10 percent oxygen, which is a well-established setting for inducing the disease.

One group of mice was engineered with sex chromosomes that were independent of their gonadal sex, or sex based on their genitalia, so that the researchers could isolate the impact of sex chromosomes. The other group of mice in the experiment had different variants of in order for the researchers to determine the impact of the presence of a Y chromosome versus varying numbers of X . All the mice had their gonads removed so that the researchers could eliminate the potential effects of .

The researchers then placed the mice in the 10 percent oxygen environment for three weeks. At the end of the experiment, the researchers examined the hearts and lungs of the . Mice with a Y chromosome experienced significantly less severe pulmonary hypertension and were protected against the development of the disease.

These findings identify a new avenue for research into effective ways to treat pulmonary hypertension. In the future, determining which genes on the Y chromosome confer protection will be vital and could lead to novel therapies for the disease.

The disease causes extreme distress to patients as well as their families. Identifying alternative, less invasive treatments would be an important step in combatting the disease, which affects hundreds of thousands of people in the United States alone, according to the American Thoracic Society.

Explore further: Lung cancer triggers pulmonary hypertension

More information: Soban Umar et al. The Y Chromosome Plays a Protective Role in Experimental Hypoxic Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine (2017). DOI: 10.1164/rccm.201707-1345LE

Related Stories

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Early echocardiography to study pulmonary hypertension in mouse model of bronchopulmonary dysplasia

July 15, 2016
Sooner is always better when it comes to diagnosing an illness and this is especially true when it comes to lung disease in premature infants, since it can have an impact on a child's health in the long-term. Researchers ...

Block estrogen to treat lung disease

August 18, 2017
The strongest epidemiological risk factor for many forms of pulmonary arterial hypertension (PAH) is female gender. Increased estrogen makes females three times more likely to develop PAH, a chronic disease that eventually ...

Pulmonary artery stiffening is an early driver of pulmonary hypertension

June 2, 2016
Pulmonary hypertension is an abnormal elevation of pressure in the pulmonary circulation that results in stress on the heart and remodeling of blood vessels in the lung. Pulmonary hypertension is caused by a variety of factors, ...

New targets for treating pulmonary hypertension found

September 8, 2014
Two new potential therapeutic targets for the treatment of pulmonary arterial hypertension, a deadly disease marked by high blood pressure in the lungs, have been identified by researchers at the University of Illinois at ...

Recommended for you

Age-related increase in estrogen may cause common men's hernia

October 16, 2018
An age-related increase in estrogen may be the culprit behind inguinal hernias, a condition common among elderly men that often requires corrective surgery, according to a Northwestern Medicine study was published Oct. 15 ...

New findings cast light on lymphatic system, key player in human health

October 16, 2018
Scientists at the Oklahoma Medical Research Foundation have broken new ground in understanding how the lymphatic system works, potentially opening the door for future therapies.

New model suggests cuffless, non-invasive blood pressure monitoring possible using pulse waves

October 16, 2018
A large team of researchers from several institutions in China and the U.S. has developed a model that suggests it should be possible to create a cuffless, non-invasive blood pressure monitor based on measuring pulse waves. ...

Discovery of inner ear function may improve diagnosis of hearing impairment

October 15, 2018
Results from a research study published in Nature Communications show how the inner ear processes speech, something that has until now been unknown. The authors of the report include researchers from Linköping University, ...

Team's study reveals hidden lives of medical biomarkers

October 12, 2018
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?

Widespread errors in 'proofreading' cause inherited blindness

October 12, 2018
Mistakes in "proofreading" the genetic code of retinal cells is the cause of a form of inherited blindness, retinitis pigmentosa (RP) caused by mutations in splicing factors.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.